Get access
  • News
Powerful Medical
•
1. June 2021

Powerful Medical opening branch in Israel

  • News

Over the past months, we have significantly strengthened our collaboration on numerous projects with our Israeli partners, such as Rabin Medical Center and Tel Aviv Medical Center, culminating in the incorporation of our Israeli subsidiary with an office on the 16th floor of the latter. We’re right in the center of all medical action and innovation, with access to local medical data to further improve the performance of our AI algorithms!

Israel is considered to be the “factory of unicorns” or “the Silicon Valley of the Middle East”, with startups such as WeWork, Waze, eToro and Fiverr originating from here.

Most tech giants have AI R&D labs in the region, giving us access to top talent, funding and technical resources.

Pictured are (from left to right): Roy Ramon (Chairman of the Board), Martin Herman (CEO) and Dr. Leor Perl (Chairman of the Scientific Board).

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

More articles
blog cover podcast pm cardio
  • News

PMcardio Featured on ‘This Week in Cardiology’: The Shift from STEMI/NSTEMI to OMI

We are thrilled to share that Powerful Medical’s PMcardio, affectionately known as the Queen of Hearts, was featured in the October 11th episode of the "This Week in Cardiology" podcast.
STEMI-mimics-cover
  • ECG cases, Education

STEMI Mimics: Spot the Subtle Impostors of Myocardial Infarction

The diagnosis of ST-Elevation Myocardial Infarction (STEMI) is a time-sensitive clinical challenge with critical implications for morbidity and mortality. However, identifying a true STEMI based solely on ECG changes is not always straightforward, as a number of other conditions, collectively termed STEMI mimics.
More articles

Join 25,000 healthcare professionals who are already taking advantage of AI

Register now

Ready to get started?

Get access

Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.

Products

Company

Resources

Legal

Envelope Linkedin-in Instagram Facebook-f

© Powerful Medical 2024

Privacy

&

Cookies

Legal

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region.

Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

PMcardio is CE-marked as class IIb medical device under EU MDR and only certified for marketing in the European Union and the United Kingdom. PMcardio technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. Not all modules of the PMcardio platform may be available in your region. Prior to use, reference the Instructions for Use, for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Sign up